FRARA, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 2.094
AS - Asia 1.823
NA - Nord America 1.456
SA - Sud America 344
AF - Africa 85
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.827
Nazione #
US - Stati Uniti d'America 1.370
RU - Federazione Russa 1.184
SG - Singapore 668
CN - Cina 516
BR - Brasile 298
IT - Italia 294
HK - Hong Kong 216
VN - Vietnam 166
SE - Svezia 161
DE - Germania 117
FR - Francia 101
GB - Regno Unito 70
IN - India 58
CA - Canada 53
EG - Egitto 35
IR - Iran 33
NL - Olanda 28
MX - Messico 26
ID - Indonesia 25
BD - Bangladesh 23
JP - Giappone 22
AU - Australia 21
FI - Finlandia 21
PL - Polonia 19
ZA - Sudafrica 19
AT - Austria 18
TR - Turchia 18
ES - Italia 17
AR - Argentina 15
IQ - Iraq 13
TN - Tunisia 13
TW - Taiwan 12
CH - Svizzera 11
IE - Irlanda 11
MA - Marocco 10
EC - Ecuador 9
CO - Colombia 8
UA - Ucraina 7
AZ - Azerbaigian 6
JO - Giordania 6
PE - Perù 6
PK - Pakistan 6
BE - Belgio 5
DK - Danimarca 5
LT - Lituania 5
SA - Arabia Saudita 5
KE - Kenya 4
PH - Filippine 4
RO - Romania 4
GR - Grecia 3
KG - Kirghizistan 3
MY - Malesia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CY - Cipro 2
IL - Israele 2
JM - Giamaica 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CL - Cile 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SZ - Regno dello Swaziland 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 5.827
Città #
Singapore 337
Moscow 277
Dallas 259
Hong Kong 209
Ashburn 208
San Jose 155
Shanghai 106
Beijing 82
Milan 77
Hefei 75
Lauterbourg 66
New York 62
Ho Chi Minh City 58
Los Angeles 45
Princeton 39
Lawrence 38
Rome 35
São Paulo 33
Hanoi 31
Munich 31
Giza 27
Montreal 26
Tehran 23
Nuremberg 21
Chennai 17
Denver 17
Orem 17
Santa Clara 17
Boardman 15
Frankfurt am Main 15
Chicago 14
Gatchina 14
London 14
Warsaw 14
Seattle 13
Tokyo 13
Council Bluffs 12
Johannesburg 12
Poplar 12
Bologna 11
Stockholm 11
Dublin 10
Houston 10
Atlanta 9
Manchester 9
Mumbai 9
Rio de Janeiro 9
Washington 9
Zurich 9
Istanbul 8
Lappeenranta 8
San Francisco 8
Vienna 8
Boston 7
Brooklyn 7
Buffalo 7
Da Nang 7
Guangzhou 7
Jakarta 7
Kaohsiung City 7
Melbourne 7
Phoenix 7
Porto Alegre 7
Shenzhen 7
The Dalles 7
Verona 7
Assago 6
Cairo 6
Columbus 6
Haiphong 6
Helsinki 6
Turku 6
Aachen 5
Ankara 5
Bandung 5
Biên Hòa 5
Brasília 5
Brussels 5
Cesano Boscone 5
Curitiba 5
Dhaka 5
Hanover 5
Lima 5
Mexico City 5
Paris 5
St Petersburg 5
Toronto 5
Torquay 5
Wilmington 5
Yekaterinburg 5
Amman 4
Amsterdam 4
Baghdad 4
Baku 4
Cannon Beach 4
Cape Town 4
City of London 4
Edmonton 4
Gainesville 4
Guarulhos 4
Totale 2.921
Nome #
Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors 481
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement 173
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows 149
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 128
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement 125
Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour? 114
COVID-19 and hypopituitarism 111
COVID-19 and the pituitary 109
Correction: Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta‑analysis 107
Distinct Clinical Features of Post-COVID-19 Vaccination Early-onset Graves' Disease 104
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 103
Novel approach to bone comorbidity in resistant acromegaly 102
Acromegalic osteopathy: An update 99
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 97
Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis 96
Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel 96
Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination 92
CURRENT AND FUTURE MEDICAL TREATMENTS FOR PATIENTS WITH ACROMEGALY. 88
Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism 88
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE) 87
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma 87
Osteopathy in mild adrenal Cushing's syndrome and Cushing disease 85
Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors 85
CURRENT AND EMERGING ASPECTS OF DIABETES MELLITUS IN ACROMEGALY. 85
Acromegalic osteopathy 84
Diabetes in Cushing Disease 83
Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly (Pituitary, 10.1007/s11102-018-0873-7) 83
Clinical Pharmacology of Oral Octreotide Capsules for the Treatment of Acromegaly 81
Bone safety of dual-release hydrocortisone in patients with hypopituitarism 79
An Italian survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 78
Pituitary Tumors Centers of Excellence 78
Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis 76
Vitamin D Levels Are Associated with Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity 76
Modern approach to resistant acromegaly 74
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 73
Correction: Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era 72
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers 69
EVIDENCE OF REDUCED MUSCLE MASS NOT ALWAYS ASSOCIATED WITH REDUCED MUSCLE STRENGTH IN POST COVID-19 PATIENTS: is this picture indicative of a recovery from acute sarcopenia 69
null 68
Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response 64
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 63
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs 62
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly 62
GH/IGF-I and bone 61
New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review 59
New tools for bone health assessment in secreting pituitary adenomas 59
Vitamin D and Glucocorticoid-Induced Osteoporosis 59
High prevalence of radiological vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma 59
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era 59
Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications 59
Treatment of hypoparathyroidism 58
Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients 58
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine 57
Pituitary Diseases and Bone 57
Malignancy risk in indeterminate thyroid nodules with Hürthle cells: role of autoimmune thyroiditis 57
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase 56
Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome 55
Primary hyperparathyroidism in prostate cancer: guilty or not guilty? 55
Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization 54
Pituitary tumor centers of excellence for Cushing's disease 54
Novel approaches to bone comorbidity in Cushing's disease: an update 53
High prevalence of radiological vertebral fractures inpatients With TSH-secreting pituitary adenoma 53
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas 53
Somatostatin analogs in the treatment of neuroendocrine tumors: Current and emerging aspects 52
Pathophysiology and evaluation of bone health in adrenal diseases 51
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 51
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects 51
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience 50
Response to the Letter to the Editor from Min et al.: Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors 50
The osteo-metabolic phenotype of COVID-19: an update 48
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 48
TSH-secreting pituitary adenomas and bone 48
THE MODERN CRITERIA FOR MEDICAL MANAGEMENT OF ACROMEGALY 47
New medical therapies of acromegaly 43
null 1
Totale 5.960
Categoria #
all - tutte 29.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202222 0 0 0 1 2 0 1 11 3 0 3 1
2022/2023319 81 72 26 11 4 40 18 18 11 2 4 32
2023/2024616 33 37 73 95 61 116 37 79 2 4 28 51
2024/20251.239 138 59 34 50 28 85 214 108 208 84 99 132
2025/20263.726 286 320 321 508 271 129 397 275 1.046 173 0 0
Totale 5.960